CN104255988A - Tea type capsules and production method thereof - Google Patents
Tea type capsules and production method thereof Download PDFInfo
- Publication number
- CN104255988A CN104255988A CN201410436146.0A CN201410436146A CN104255988A CN 104255988 A CN104255988 A CN 104255988A CN 201410436146 A CN201410436146 A CN 201410436146A CN 104255988 A CN104255988 A CN 104255988A
- Authority
- CN
- China
- Prior art keywords
- parts
- capsule
- tea
- capsule shells
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of foods and health products and particularly relates to tea type capsules and a production method thereof. The tea type capsules are composed of capsule shells and a mixed solution filling the capsule shells, wherein the mixed solution in the tea type capsule shells is prepared from the following raw materials in parts by weight: 320-380 parts of tea polyphenols, 90-120 parts of theaflavin, 45-75 parts of ginkgo leaf extract, 20-35 parts of marigold extract, 18-42 parts of plant extracting oil, 15-30 parts of phospholipid and 12-28 parts of beeswax; and the capsule shells are prepared from the following raw materials in parts by weight: 6-16 parts of beeswax, 8-24 parts of pectin, 6-20 parts of maltodextrin and 10-30 parts of purified water. The prepared mixed solution raw materials and the capsule shell raw materials are pressed into the capsules. The tea type capsules have a unique formula, are prepared from the extract of natural plant raw materials without essences, synthetic pigments or preservatives, have diversified nutrition, can be used for effectively alleviating and preventing high blood pressure, high blood fat and high blood glucose, and can be used for effectively improving memory and immunity.
Description
Technical field
The present invention relates to health-care food manufacture field, especially relate to a kind of tea race capsule and preparation method thereof
Background technology
Tea is not only a kind of beverage, the effect of have quenching one's thirst, refreshing oneself, and has stronger health care.Write in Shennong's Herbal: " shennong went into the mountains collecting, tasting and testing different kinds of herbs to be used as medicine, meets 72 poison day, obtain tea and separate it ", record in supplement to the Herbal: " all medicines are the medicine of each disease, and tea is the medicine of this disease ", tea has " separate greasy, remove people's fat " prevents cardiovascular and cerebrovascular disease function.The mode that in daily life, people drink tea, lower to absorbing of Tea Polyphenols, major part is all along with tea waste residue abandons together.Containing the material such as Tea Polyphenols, catechin extracted leaf, there is anti-freezing from tea; short fibrinolytic; anti-platelet aggregation, hypotensive, reducing blood lipid; prevent and treat atherosclerotic; the effects such as protection cardiac muscle, and the absorption of cholesterol in food can be reduced or increase the speed that cholesterol and triglyceride drain from enteron aisle and the activity suppressing cholesterol synthase, the quantity of minimizing synthetic cholesterol; thus lower cholesterol in human body concentration, thus reach the effect reducing blood fat.
Along with improving constantly of people's living standard quality, most people crowd is in overnutrition state, " three is high " crowd is caused to be on the increase, according to statistics, the whole world is every year because " three is high " disease causes the number of cardiovascular and cerebrovascular disease death up to 1,500 ten thousand people, the cardio-cerebral diseases population of current China is more than hundred million people, and cardiovascular and cerebrovascular disease has become as the dead virus of harm humans is because of the highest number one killer." three is high " in daily life is all by health care prevention conditioning and drug therapy.For this reason, occur manyly from tealeaves, extracting health products prepared by Tea Polyphenols in the market, medicine, food, beverage all have good health care and a result for the treatment of, all achieve fine economic benefit and social benefit, but most products all contains chemical agent, various unconformable situation can be produced after people takes, there is larger side effect, can not long-term taking.
Summary of the invention
Goal of the invention of the present invention is: for above-mentioned Problems existing, there is provided a kind of utilization from the plants such as tealeaves, extract natural nutrient substance and prepare tea race capsule health-care food, obtained tea race capsule quality is reliable, composition natural goods chemical composition, mixed liquor in capsule shells is stablized, easily be rapidly absorbed by a human, there is the function of reducing blood lipid, hypotensive, softening blood vessel, anti-oxidant, anti-ageing and develop immunitypty.
Use the technical solution used in the present invention is as follows:
A kind of tea race capsule, be made up of capsule shells and the mixed liquor be filled in capsule shells, it is characterized in that: the mixed liquor in described tea race capsule shells is made up of the raw material of following weight portion: Tea Polyphenols 320-380 part, theaflavin 90-120 part, ginkgo biloba p.e 45-75 part, Flos Tagetis Erectae extract 20-35 part, plant extract oil 18-42 part, phosphatidase 1 5-30 part, cera flava 12-28 part, described capsule shells is made up of the raw material of following weight portion: cera flava 6-16 part, pectin 8-24 part, maltodextrin 6-20 part, purified water 10-30 part.
Preferably, mixed liquor in described tea race capsule shells is made up of the raw material of following weight portion: Tea Polyphenols 350 parts, theaflavin 110 parts, ginkgo biloba p.e 60 parts, Flos Tagetis Erectae extract 28 parts, plant extract oil 30 parts, phosphatidase 22 parts, cera flava 20 parts, and described capsule shells is made up of the raw material of following weight portion: cera flava 10 parts, pectin 16 parts, maltodextrin 12 parts, purified water 22 parts.
Further preferably, described vegetable oil is one or more mixtures in wheat-germ oil, soybean embryo fat/oil, corn oil, sesame oil, tea-seed oil, fiery sesame oil.
Preferably, described vegetable oil is wheat-germ oil.Vitamin E in natural wheat-germ oil, provides needed by human unrighted acid, as leukotrienes and linoleic acid.
A preparation method for tea race capsule, is characterized in that comprising the following steps:
(1) take capsule shells by weight respectively and be filled in the mixed liquor raw material in capsule shells, wherein contents mixed liquid raw material: Tea Polyphenols 320-380 part, theaflavin 90-120 part, ginkgo biloba p.e 45-75 part, Flos Tagetis Erectae extract 20-35 part, plant extract oil 18-42 part, phosphatidase 1 5-30 part, cera flava 12-28 part, described capsule shells is made up of the raw material of following weight portion: cera flava 6-16 part, pectin 8-24 part, maltodextrin 6-20 part, purified water 10-30 part.
(2) mixed liquor raw material preparation: put into glue tank after cera flava being joined vegetable oil, slowly be heated to cera flava and dissolve rear cooling completely, add phosphatide again to stir, then ginkgo biloba p.e, Flos Tagetis Erectae extract is added, add again to insert in colloid mill after Tea Polyphenols and theaflavin are uniformly mixed mill 8 ~ 15 minutes after filter, and put into vacuum tank and place stand-by;
(3) capsule shells raw material preparation: purified water is dropped in glue tank and be heated to 65 ~ 75 DEG C, add cera flava, pectin and maltodextrin more fully to stir and to carry out vacuum defoamation after 30 ~ 40min fully mixes and sampling detects moisture, thus obtained capsule shells, place stand-by;
(4) be pressed into capsule: mixed liquor raw material obtained in step (2) and the obtained capsule shells raw material of step (3) are injected encapsulating machine pelleting, then the capsule and pill made is carried out shape, heated drying, refining, the obtained capsule finished product of packaging after cleaning, again cool-drying.
Preferably, in described step (4), the thickness of the capsule shells that pelleting obtains is 0.85 ~ 0.95mm..
Preferably, the quality of the tea race capsule that described step (4) is obtained is 600 ~ 650mg/ grain.
In the present invention, Tea Polyphenols in described formula, theaflavin, ginkgo biloba p.e, Flos Tagetis Erectae extract, plant extract oil, phosphatide, cera flava are all the materials extracted from natural plants, there is higher nutritive value, be widely used in the industrial processes such as medicine, food, beverage, health products and production.Prevent the active ingredient adding mixed liquor in man-hour oxidized at the bright middle plant extract oil of this law, phosphatide and cera flava.Wherein, containing vitamin E, unrighted acid in plant extract oil, as leukotrienes and linoleic acid can auxiliarily reducing blood lipid.
Tea Polyphenols (Tea Polyphenols) is the general name of more than 30 kind of polyphenols in tealeaves, comprises flavanol compound (catechin), anthocyanin class, flavonoids, flavonols and phenolic acid class etc.Tea Polyphenols is the All Pure Nature antioxidant food extracted from tealeaves, has oxidation resistance strong, has no side effect, the features such as free from extraneous odour.Tea Polyphenols is used as antioxidant and bactericide in food, prevents food spoilage, extends the shelf life.At medical field, Tea Polyphenols is used for prevention and cure of cardiovascular disease, reducing blood lipid, the congee sample artery sclerosis that prevention lipid peroxidation causes, hypoglycemic, prevention and therapy diabetes etc.
Theaflavin (Theaflavin) is the golden yellow pigment of the one be present in yellow tea, black tea, is the product of tea leaf fermentation.In biochemistry, theaflavin is the material of class polyphenol hydroxyl tool tea a pair of horses going side by side phenolic ketone structure.The theaflavin being described as " soft gold " in tealeaves has the unique function of reducing blood lipid, angiocardiopathy preventing, and has no side effect.Theaflavin not only can be combined the absorption reducing cholesterol in food by the cholesterol in enteron aisle, can also suppress the cholesterol biosynthesis of human body self.
The medical value of ginkgo biloba p.e is very extensive with application; may be used for Improving memory power, anti-inflammatory, antiallergy, hemangiectasis, protection cardiovascular and cerebrovascular, improve peripheral blood circulation, reduce the aspect such as serum cholesterol and anticancer adjuvant and play drug effect, the control of the systemic disease such as cardiovascular and cerebrovascular, nerve and health care etc. can be widely used in.In the present invention, ginkgo biloba p.e conventionally extracts, and extracting method is carried out as follows;
(a) by fresh, without insect pest ginkgo leaf dry moisture content, the moisture content of oven dry is 40% ~ 60%, then ginkgo leaf powder is broken to 35 ~ 50 orders;
B () added the alcohol immersion of 65% ~ 70% of 10 ~ 12 times of ginkgo leaf quality after 6 hours, extract 3 times, then filter, evaporate, concentration and recovery ethanol obtains ginkgo leaf concentrated extracting solution;
C () adds in ginkgo leaf concentrated extracting solution with the ethanol of 20 ~ 25, to soak 20 minutes and after stirring, centrifugal extraction again, remove precipitation and impurity, the pH value of concentrate is being adjusted to 8 ~ 9.5, is placing after 20 ~ 30 minutes, centrifugal extraction 2 times again, and then the concentrate of gained is added hydrochloric acid, again regulate pH value to 3.5 ~ 5 of concentrate, and extract 3 times;
D ginkgo extract obtained by step (c) is crossed macroreticular resin and is carried out deionized water wash-out by (), and reduced pressure concentration, vacuum drying, obtains ginkgo biloba p.e.
Flos Tagetis Erectae extract main containing four kinds of natural carotenoid, beta carotene, alpha-carotene, lutein (lutein) and luteole (zeaxanthin) respectively, these four kinds natural carotenoid, have delay senility and anti-sudden change, improve immunity, preventing ocular diseases fallen, the illness rate of low colorectal cancer and heart disease has the very significant effect of performance.In the present invention, mainly adopt by marigold flower as raw material, by marigold flower at normal temperatures, carry out sealing and fermenting 15 ~ 20 days, then put into vacuum-tight extruder to pulverize, and add leaching solvent squeezing, filtration, collection filtrate, at normal temperatures, extract is put into evaporimeter to carry out concentrated obtaining stoste, for subsequent use to do in the tank that the plant extract oil finally gained concentrate being added 3% ~ 5% carries out allocating sealing.
In sum, tea race of the present invention capsule has following significant advantage:
(1) raw material adopted is the extract of natural plant raw material, does not add spices, synthetic dyestuff, not containing anticorrisive agent, ensure that the ecological, environmental protective of tea race capsule 100%.
(2) capsule good springiness, be easy to swallow, be filled in the mixed liquor steady quality in capsule shells,
(3) formula of the technology of the present invention is unique, and tea race capsule has nutrition diversification, can effectively improve and prevent conditioning blood pressure, blood fat and blood sugar, and also effective Improving memory power and immunity simultaneously.
(4) production technology is simple, the cycle is short, cost is low, is convenient to industrial mass production.
Detailed description of the invention
Below by embodiment, the invention will be further described.
Embodiment 1
A kind of tea race capsule, be made up of capsule shells and the mixed liquor be filled in capsule shells, wherein, the mixed liquor in capsule shells is made up of the raw material of following weight portion: Tea Polyphenols 320 parts, theaflavin 90 parts, ginkgo biloba p.e 45 parts, Flos Tagetis Erectae extract 20 parts, plant extract oil 18 parts, phosphatidase 15 parts, cera flava 12 parts; Capsule shells is made up of the raw material of following weight portion: cera flava 6 parts, pectin 8 parts, maltodextrin 6 parts, purified water 10 parts.
The preparation method of above-mentioned tea race capsule is as follows:
(1) take capsule shells by weight respectively and be filled in the mixed liquor raw material in capsule shells;
(2) mixed liquor raw material preparation: put into glue tank after cera flava being joined vegetable oil, slowly be heated to cera flava and dissolve rear cooling completely, add phosphatide again to stir, then ginkgo biloba p.e, Flos Tagetis Erectae extract is added, finally add to insert in colloid mill after Tea Polyphenols and theaflavin are uniformly mixed mill 8 ~ 15 minutes after filter, and put into vacuum tank and place stand-by;
(2) capsule shells raw material preparation: purified water is dropped in glue tank and be heated to 65 ~ 75 DEG C, add cera flava, pectin and maltodextrin more fully to stir and to carry out vacuum defoamation after 30 ~ 40min fully mixes and sampling detects moisture, thus obtained capsule shells, place stand-by;
(3) capsule is pressed into: the capsule shells raw material that mixed liquor raw material obtained in step (2) and step (3) obtain is injected encapsulating machine pelleting, the thickness of its obtained capsule shells is 0.85 ~ 0.95mm, quality is 600 ~ 650mg/ grain, then the capsule and pill made is carried out shaping, heated drying, refining, the obtained capsule finished product of packaging after cleaning, again cool-drying.
Embodiment 2
A kind of tea race capsule, be made up of capsule shells and the mixed liquor be filled in capsule shells, wherein, the mixed liquor in capsule shells is made up of the raw material of following weight portion: Tea Polyphenols 300 parts, theaflavin 90 parts, ginkgo biloba p.e 50 parts, Flos Tagetis Erectae extract 30 parts, plant extract oil 15 parts, phosphatidase 20 part, cera flava 15 parts; Capsule shells is made up of the raw material of following weight portion: cera flava 8 parts, pectin 10 parts, maltodextrin 15 parts, purified water 20 parts.
The preparation method of above-mentioned tea race capsule is identical with embodiment 1.
Embodiment 3
A kind of tea race capsule, be made up of capsule shells and the mixed liquor be filled in capsule shells, wherein, mixed liquor in capsule shells is made up of the raw material of following weight portion: Tea Polyphenols 270 parts, theaflavin 75 parts, ginkgo biloba p.e 40 parts, Flos Tagetis Erectae extract 20 parts, plant extract oil 10 parts, phosphatidase 15 parts, cera flava 10 parts, and described capsule shells is made up of the raw material of following weight portion: cera flava 5 parts, pectin 6 parts, maltodextrin 9 parts, purified water 16 parts.
The preparation method of above-mentioned tea race capsule is identical with embodiment 1.
Embodiment 4: security performance is tested
1, animal used as test: healthy normal mouselet, 6 ~ 8 week age, body weight: 22 ~ 25g.
Laboratory sample: tea race capsule prepared by Example 3 is sample, be light yellow under being filled in the mixed liquor normal temperature in capsule shells, adult recommends consumption to be 3/60kg.bw every day, prepares tested mouselet during experiment with distilled water as solvent.
2, experimental technique
Product of the present invention is evaluated mouselet acute oral toxicity test, Ames experiment according to toxicological assessment standard, verifies that this product is nontoxic.
(1) acute oral toxicity test: by 30 mouselets, each 15 of male and female, often organize 15, experiment establishes 15000mg/kg.wb dosage group by receiving most dosimetry greatly, at interval of 4 hours per os gavages, each gavage 20mg/kg.wb, fasting 16 hours before gavage, do not limit drinking-water, observe the intoxication conditions of animal in 30 days.
During 30 days feed to beverage, having no mouselet has poisoning and dead disease, and experiment terminates rear execution mouselet anatomic observation no abnormality seen, and mouselet acute oral MTD is all greater than 15000mg/kg.wb, belongs to nontoxic level by toxicity grading.Concrete outcome is in table 1.
Table 1 mouselet acute oral toxicity test result
| Sex | Dosage (mg/kg.wb) | Size of animal (only) | Death condition | MTD(mg/kg.wb) |
| Female | 15000 | 15 | 0 | >15000 |
| Male | 15000 | 15 | 0 | >15000 |
(2) Ames experiment: the mixed liquor selecting variable concentrations, add or do not add using homemade Polychlorinated biphenyls rats'liver S9 derivant to test, its Genetic toxicity result is negative.
Embodiment 5: the test of blood fat reducing function
1, case selection:
(1) according to " auxiliary antilipemic evaluation method function ", in normal diet situation, the blood lipid level of fasting after 12 ~ 14 hours is detected.Twice lipids detection is had at least in half a year.
(2) criterion: the scope of serum total cholesterol (TC) is within 5.17 ~ 6.21mmol/L, TC are down to normal range (NR) or decline >=20%, or declines within 10% ~ 20%;
The scope of serum levels of triglyceride (TG) is within 1.69 ~ 2.25mmol/L, TG are down to normal range (NR) or decline >=20%, or declines within 20% ~ 40%;
The scope of HDL-C (HDL-C) is within 0.91 ~ 1.04mmol/L, HDL-C rise to normal range (NR) or rising >=0.26mmol/L, or lifting range is at 0.104 ~ 0.26mmol/L;
The scope of LDL-C (LDL-C) is within 3.10 ~ 3.59mmol/L, HDL-C drop to normal range (NR) or decline >=20%, or decline scope is within 10% ~ 20%;
(3) case source: it is clearly dyslipidemia, hypertension, coronary heart disease apoplexy or Patients with Cardiovascular/Cerebrovascular Diseases 300 example that case is, in this group case, the male sex 210 example, women 90 example, the age was at 48 ~ 72 years old, treatment group and control group is divided at random by 2:1, treatment group 200 example, the male sex is 146 examples, women 38 example, TC increases 163 examples, and TG increases 101 examples; Control group, the male sex is 64 examples, women 36 example, and TC increases 79 examples, and TG increases 54 examples, and the patient of two groups is same living area, and the environment of life is substantially identical, and between two groups, blood fat height low degree all very big-difference, has comparativity.
(4) experimental technique: treatment group, select the tea race capsule of embodiment 3, each serving 1, take 3 every day, one after each meal, within 1 month, be 1 course for the treatment of, taking the medicine of period inactive other influences blood fat, blood viscosity, control group is the tablets of reducing blood fat health products (20mg/ sheet) of other boards, each 2, every day 3 times, one after each meal 30 days is 1 course for the treatment of.All the other treatment groups are identical.Wherein, table 2 be the test result of tea race capsule blood fat reducing function as shown.
The test result of table 2 tea race capsule blood fat reducing function
Test result analysis according to table 2: the tablets of reducing blood fat health products taking the bright tea race capsule of this law and other brands continuously compared with 2 months, all effectively improve the clinical symptoms of patient, the serum total cholesterol (TC) of patient, serum levels of triglyceride (TG), HDL-C (HDL-C) and LDL-C (LDL-C) have reduction, but the reducing blood lipid for the treatment of group and contrast groups relatively has obviously, the Be very effective for the treatment of group is higher than control group, illustrate that the health food of tea race of the present invention capsule has good blood-fat-decreasing function.
Embodiment 6: use-case
(1) falling tone joint blood sugar, hypotensive, blood fat
Certain man, 57 years old, cook, reason due to working environment causes and is eaten up with illness, and suffer from diabetes, apoplexy, cardiovascular and cerebrovascular disease etc., disease is enjoyed to torment for a long time, often with dizziness, feel sick, the symptoms such as vomiting, once a sick cerebral thrombus, in hospitalize more than a year, state of an illness therapeutic advance is slowly not improved, under the suggestion of doctor, this man takes tea race capsule from July, 2013, every day three times, each one, after 2 months, the sensation state of an illness is alleviated to some extent, spirit takes a turn for the better, blood sugar drops to 8.2mmol/L by 17.6mmol/L originally, and blood fat, cholesterol, triglyceride all presents downward trend, after continuing to take 9 months, blood sugar drops to 5.8mmol/L, and blood fat, cholesterol, triglyceride all reaches normal value, cerebral thrombosis disease and cardiovascular and cerebrovascular disease all take an evident turn for the better.As can be seen here, tea race of the present invention capsule significantly can reduce the complication that blood sugar prevention diabetes cause, there is very strong oxidation resistance simultaneously, the harm of cylinder super-oxidation lipid to blood vessel can be reduced, prevent vascular sclerosis, the content of the triglyceride in effective reduction human body, therefore tea race of the present invention capsule has significant effect for hypertension, high fat of blood and the hyperglycaemia that prevention is middle-aged and old, often take tea race capsule and there is health care that is hypotensive, adjusting blood lipid, be good for one's health longevity, improves the quality of living.
(2) immunity is promoted
Certain Ms, 63 years old, retired professor, passive protective physical fitness is poor, and weather changes or seasonal variations, frequent cold, under the introduction of friend, take from November, 2013, every day one after each meal tea race capsule, every day three times, each one, take after two months, strengthen on the basis of outdoor exercise motion, health has larger improvement, and physique obviously strengthens simultaneously, no matter the cold and Warm Changes in Northern of weather, the conversion in season, the transference cure of cold.As can be seen here, tea race of the present invention capsule plays immunoadjuvant effect, and can stimulate the immunity function of human body, play a role immune effect better, improves immunocompetence, often takes tea race capsule and has the health care improving immunity.
The foregoing is only preferred embodiment of the present invention, not in order to limit the present invention, within the spirit and principles in the present invention all, any amendment made, equivalent replacement, improvement, all should comprise within the scope of the present invention.
Claims (7)
1. a Zhong Cha race capsule, be made up of capsule shells and the mixed liquor be filled in capsule shells, it is characterized in that: the mixed liquor in described tea race capsule shells is made up of the raw material of following weight portion: Tea Polyphenols 320-380 part, theaflavin 90-120 part, ginkgo biloba p.e 45-75 part, Flos Tagetis Erectae extract 20-35 part, plant extract oil 18-42 part, phosphatidase 1 5-30 part, cera flava 12-28 part, described softgel shell is made up of the raw material of following weight portion: cera flava 6-16 part, pectin 8-24 part, maltodextrin 6-20 part, purified water 10-30 part.
2. a kind of tea race according to claim 1 capsule, be made up of capsule shells and the mixed liquor be filled in capsule shells, it is characterized in that: the mixed liquor in described tea race capsule shells is made up of the raw material of following weight portion: Tea Polyphenols 350 parts, theaflavin 110 parts, ginkgo biloba p.e 60 parts, Flos Tagetis Erectae extract 28 parts, plant extract oil 30 parts, phosphatidase 22 parts, cera flava 20 parts, described softgel shell is made up of the raw material of following weight portion: cera flava 10 parts, pectin 16 parts, maltodextrin 12 parts, purified water 22 parts.
3. a kind of tea race according to claim 1 and 2 capsule, is characterized in that: described vegetable oil is one or more mixtures in wheat-germ oil, soybean embryo fat/oil, corn oil, sesame oil, tea-seed oil, fiery sesame oil.
4. a kind of tea race according to claim 3 capsule, its feature with: described vegetable oil is wheat-germ oil.
5. the preparation method of a Zhong Cha race capsule, is characterized in that comprising the following steps:
(1) take capsule shells by weight respectively and be filled in the mixed liquor raw material in capsule shells, wherein contents mixed liquid raw material: Tea Polyphenols 320-380 part, theaflavin 90-120 part, ginkgo biloba p.e 45-75 part, Flos Tagetis Erectae extract 20-35 part, plant extract oil 18-42 part, phosphatidase 1 5-30 part, cera flava 12-28 part, described capsule shells is made up of the raw material of following weight portion: cera flava 6-16 part, pectin 8-24 part, maltodextrin 6-20 part, purified water 10-30 part;
(2) mixed liquor raw material preparation: put into glue tank after cera flava being joined vegetable oil, slowly be heated to cera flava and dissolve rear cooling completely, add phosphatide again to stir, then ginkgo biloba p.e, Flos Tagetis Erectae extract is added, add again to insert in colloid mill after Tea Polyphenols and theaflavin are uniformly mixed mill 8 ~ 15 minutes after filter, and put into vacuum tank and place stand-by;
(3) capsule shells raw material preparation: purified water is dropped in glue tank and be heated to 65 ~ 75 DEG C, add cera flava, pectin and maltodextrin more fully to stir and to carry out vacuum defoamation after 30 ~ 40min fully mixes and sampling detects moisture, thus obtained capsule shells, place stand-by;
(4) be pressed into capsule: mixed liquor raw material obtained in step (2) and the obtained capsule shells raw material of step (3) are injected encapsulating machine pelleting, then the capsule and pill made is carried out shape, heated drying, refining, the obtained capsule finished product of packaging after cleaning, again cool-drying.
6. the preparation method of a kind of tea race according to claim 5 capsule, is characterized in that: in described step (4), the thickness of the capsule shells that pelleting obtains is 0.85 ~ 0.95mm..
7. the preparation method of a kind of tea race according to claim 5 capsule, is characterized in that: the quality of the tea race capsule that described step (4) is obtained is 600 ~ 650mg/ grain.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410436146.0A CN104255988A (en) | 2014-08-29 | 2014-08-29 | Tea type capsules and production method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410436146.0A CN104255988A (en) | 2014-08-29 | 2014-08-29 | Tea type capsules and production method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104255988A true CN104255988A (en) | 2015-01-07 |
Family
ID=52147674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410436146.0A Pending CN104255988A (en) | 2014-08-29 | 2014-08-29 | Tea type capsules and production method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104255988A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105106169A (en) * | 2015-09-23 | 2015-12-02 | 威海紫光金奥力生物技术有限公司 | Shell-broken ganoderma lucidum spore powder capsule and preparation method thereof |
| CN106538674A (en) * | 2016-12-06 | 2017-03-29 | 钦州阜康农副食品有限公司 | A kind of method of mango fresh-keeping |
| CN106665806A (en) * | 2016-12-06 | 2017-05-17 | 钦州阜康农副食品有限公司 | Fresh keeping method for melons and fruits |
| CN109566803A (en) * | 2018-12-26 | 2019-04-05 | 福建省蓝湖食品有限公司 | A kind of tea juice capsule and its manufacturing method and its release tool and its method for releasing |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1476830A (en) * | 2003-07-17 | 2004-02-25 | 新疆特丰药业股份有限公司 | Tea-polyphenol soft capsule and its preparation process |
| CN1799541A (en) * | 2004-12-30 | 2006-07-12 | 天津中新药业集团股份有限公司 | Soybean isoflavone soft capsule and its preparation process |
| CN1947733A (en) * | 2005-10-14 | 2007-04-18 | 北京联合伟华药业有限公司 | Soft capsule prepn. contg. Sarcandra glaber, and its prepn. method |
| CN101278965A (en) * | 2008-05-26 | 2008-10-08 | 北京星昊医药股份有限公司 | Soft capsule of humifuse spurge and preparing method thereof |
| CN101284027A (en) * | 2008-06-10 | 2008-10-15 | 云南中研万通生物科技有限公司 | Preparation method of capsules for reducing blood fat |
| CN101433631A (en) * | 2007-11-16 | 2009-05-20 | 北京因科瑞斯医药科技有限公司 | Antiradiation composition for improving immunity and preparation method thereof |
| JP4913340B2 (en) * | 2003-11-21 | 2012-04-11 | 湧永製薬株式会社 | Capsule |
| CN102552732A (en) * | 2012-02-23 | 2012-07-11 | 淄博金硕生物科技有限公司 | Chinese medicinal preparation or Chinese medicinal health care product with effect of reducing blood fat |
-
2014
- 2014-08-29 CN CN201410436146.0A patent/CN104255988A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1476830A (en) * | 2003-07-17 | 2004-02-25 | 新疆特丰药业股份有限公司 | Tea-polyphenol soft capsule and its preparation process |
| JP4913340B2 (en) * | 2003-11-21 | 2012-04-11 | 湧永製薬株式会社 | Capsule |
| CN1799541A (en) * | 2004-12-30 | 2006-07-12 | 天津中新药业集团股份有限公司 | Soybean isoflavone soft capsule and its preparation process |
| CN1947733A (en) * | 2005-10-14 | 2007-04-18 | 北京联合伟华药业有限公司 | Soft capsule prepn. contg. Sarcandra glaber, and its prepn. method |
| CN101433631A (en) * | 2007-11-16 | 2009-05-20 | 北京因科瑞斯医药科技有限公司 | Antiradiation composition for improving immunity and preparation method thereof |
| CN101278965A (en) * | 2008-05-26 | 2008-10-08 | 北京星昊医药股份有限公司 | Soft capsule of humifuse spurge and preparing method thereof |
| CN101284027A (en) * | 2008-06-10 | 2008-10-15 | 云南中研万通生物科技有限公司 | Preparation method of capsules for reducing blood fat |
| CN102552732A (en) * | 2012-02-23 | 2012-07-11 | 淄博金硕生物科技有限公司 | Chinese medicinal preparation or Chinese medicinal health care product with effect of reducing blood fat |
Non-Patent Citations (1)
| Title |
|---|
| 梅之南等: "灵丹草软胶囊制备工艺的研究", 《中国药师》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105106169A (en) * | 2015-09-23 | 2015-12-02 | 威海紫光金奥力生物技术有限公司 | Shell-broken ganoderma lucidum spore powder capsule and preparation method thereof |
| CN106538674A (en) * | 2016-12-06 | 2017-03-29 | 钦州阜康农副食品有限公司 | A kind of method of mango fresh-keeping |
| CN106665806A (en) * | 2016-12-06 | 2017-05-17 | 钦州阜康农副食品有限公司 | Fresh keeping method for melons and fruits |
| CN109566803A (en) * | 2018-12-26 | 2019-04-05 | 福建省蓝湖食品有限公司 | A kind of tea juice capsule and its manufacturing method and its release tool and its method for releasing |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106616979B (en) | Preparation method and application of turmeric fruit and vegetable enzyme | |
| CN102228180B (en) | Betelnut buccal tablet and preparation method thereof | |
| CN104287036B (en) | A kind of Chinese herbal medicine green tea health vinegar beverage and production technology | |
| CN101664184A (en) | Healthcare product for reducing blood fat and preparation method thereof | |
| CN102669306B (en) | Vitamin-E-enriched tea oil and preparation method thereof | |
| Lagos et al. | Recent patents on the application of bioactive compounds in food: a short review | |
| CN105125663A (en) | Preparation method of red raspberry extract | |
| CN108782874A (en) | A kind of selenium-rich black tea drinks | |
| CN107996757A (en) | A kind of blood pressure lowering, hypoglycemic, reducing blood lipid, the health beverages and preparation method thereof of norcholesterol | |
| CN104255988A (en) | Tea type capsules and production method thereof | |
| CN102499296A (en) | Rosa roxbunghii fruit tea bag and preparation method thereof | |
| CN109694805A (en) | A kind of formula and preparation method thereof of the friendly tender tea leaves alcoholic drink mixed with fruit juice of sugar | |
| KR101812725B1 (en) | Manufacturing method for pills using medical plants comprising ginseng and pills using medical plants comprising ginseng manufactured by the same | |
| CN101884408B (en) | Ginkgo leaf leaching liquor and preparation method thereof | |
| CN107048160A (en) | Fruits and vegetables rice flour produts that a kind of diabetes patient is applicable and preparation method thereof | |
| CN104186657B (en) | A kind of bighead atractylodes rhizome milk vinegar green-tea health-care beverage | |
| CN102423070A (en) | Natto capsule and its preparation method | |
| CN101096627B (en) | Loquat flower wine and method for making same | |
| Boublenza et al. | Carob as source for sustainable ingredients and products | |
| KR102501955B1 (en) | A composition for immune enhancement comprising benicasa hispida extract | |
| CN104585574A (en) | Propolis soft capsule product and preparation method thereof | |
| CN107736542A (en) | A kind of compound lozenge of blueberry and preparation method thereof | |
| CN104435072B (en) | A kind of extract and preparation method thereof with auxiliary hyperglycemic, reducing blood lipid | |
| CN102613349B (en) | Ginkgo garlic yellow tea composite particle drink | |
| CN105724539A (en) | Blood sugar reducing dietary biscuits and preparation method therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150107 |
|
| WD01 | Invention patent application deemed withdrawn after publication |